Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Vitamin D supplementation in patients with atopic dermatitis, chronic urticaria or contact dermatitis – possible improvements without risk (CROSBI ID 307740)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Lugović Mihić, Liborija ; Mandušić, Nikolina ; Pondeljak, Nives ; Kuna, Matea ; Pozderac, Iva Vitamin D supplementation in patients with atopic dermatitis, chronic urticaria or contact dermatitis – possible improvements without risk // Folia medica, 64 (2022), 3; 467-477. doi: 10.3897/folmed.64.e66166

Podaci o odgovornosti

Lugović Mihić, Liborija ; Mandušić, Nikolina ; Pondeljak, Nives ; Kuna, Matea ; Pozderac, Iva

engleski

Vitamin D supplementation in patients with atopic dermatitis, chronic urticaria or contact dermatitis – possible improvements without risk

Introduction: There has been a lot of talk lately about the importance of reduced serum vitamin D levels and their supplementation for patients with inflammatory skin diseases such as atopic dermatitis (AD) as well as other allergic diseases. The serum vitamin D values are associated with a number of factors such as limited sunlight exposure (modern lifestyle, extended indoor stay, enhanced sun protection, etc.) which can affect different diseases. Aim: Evaluating serum vitamin D values in patients with inflammatory skin diseases, comparing them on the basis of other parameters (age, gender/sex, residential areas, total serum IgE), and establishing if vitamin D supplementation would affect the improvement of the clinical picture of the disease. Patients and Methods: A total of 157 patients participated in this prospective study: 51 patients with AD, 55 with chronic urticaria (CU) and 51 with contact dermatitis (CD): 38 with irritant CD (ICD) and 13 with allergic CD (ACD). In all patients, the values of serum vitamin D were determined by chemiluminescence microparticle immunoassay (CMIA) and compared by diagnosis, age, sex, living environment, values of total IgE. In patients with reduced values of vitamin D, its supplementation for 3 months was recommended, after which the second evaluation of D vitamin values and disease status were determined and compared with an untreated/unsupplemented group with normal vitamin D values. Results: Vitamin D deficiency was often observed in patients with AD, CU and CD, most frequently in the ICD group, and least frequently in the ACD group. No significant differences were found in terms of age, gender or living environment, nor did they correlate with total IgE. In the subjects supplemented with vitamin D, their levels increased significantly and, after its supplementation, improvement of the clinical condition was more common than in the untreated group ; however, the differences were not statistically significant (69.8 vs 58.1 ; p=0.428). Conclusion Although the serum vitamin D levels of the groups did not differ significantly, the supplementation of vitamin D in patients with prominent vitamin D deficiency may be useful and crucial for improving the prognosis of the disease.

allergic diseases ; eczema ; vitamin D deficiency ; cholecalciferol ; skin inflammatory diseases

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

64 (3)

2022.

467-477

objavljeno

0204-8043

1314-2143

10.3897/folmed.64.e66166

Povezanost rada

Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)

Poveznice
Indeksiranost